News

Vaccinogen Names Veteran Biotech Executive Michael Kranda President & CEO

Learn more >>

Vaccinogen Announces New Relationship with CRO Clinipace Worldwide

Learn more >>

August 26, 2009 – Vaccinogen BV passes inspection and receives a new certificate of cGMP.

Learn more >>

Michael G. Hanna, Jr., Ph.D. discusses OncoVAX® at the Cancer Immunotherapy: A Long-Awaited Reality Conference in NY.

FDA Approval

Special Protocol Assessment
Learn More >>

Fast Track
Learn more >>

Publications

Human Vaccines 2006
Active Specific Immunotherapy with Autologous Tumor Cell Vaccines
Learn more >>

Cancer Vaccine Space

Vaccinogen is uniquely positioned within the cancer vaccine space
Learn more >>